New Anti TB drug (2)
--------------------
cross-posted from e-drug:
New TB Therapy May Halve Treatment Time
Dear E-druggers,
Why another (patented) quinolone for tuberculosis treatment when
ofloxacin is already on the WHO list for the same indication?
Are there any comparative trials? Published? Where? And has
ofloxacin - which has a number of disturbing CNS side effects -
ever been critically compared with older off-patent quinolones?
What about development of resistance? It is alright if hard data
are available, otherwise it is just another gimmick to push the
N-th me-too drug. Patients are not helped with empty promises.
Best wishes,
Leo Offerhaus
Netherlands
mailto:offerhausl@euronet.nl
--
Beverley Snell
Centre for International Health
Macfarlane Burnet Institute for Medical Research & Public Health
GPO Box 2284, Melbourne 3001 Australia
Site: Alfred Medical Research & Education Precinct (AMREP)
85 Commercial Road, Prahran 3181
Tel. +61-3-9282-2115 / 9282-2275
Fax: +61-3-9282-2144 or 9282-2100
Time zone: 10 hours ahead of GMT.
mailto:bev@burnet.edu.au
http://www.burnet.internationalhealth.edu.au